PharmacoEconomics & Outcomes News

, Volume 844, Issue 1, pp 26–26 | Cite as

Novel inhaler reduces costs and environmental burden

Non-clinical study


  1. Ortsater G, et al. Incorporating the Environmental Impact into a Budget Impact Analysis: The Example of Adopting RESPIMAT Re-usable Inhaler. Applied Health Economics and Health Policy : 6 Dec 2019. Available from: URL:

Copyright information

© Springer International Publishing AG 2020

Personalised recommendations